Real-time enrollment status for this heart attack clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06139328 |
| Recruiting Status | Terminated |
| Condition | Heart Attack |
| Phase | Clinical Trial |
| Target Enrollment | 350 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06139328 is currently terminated participants. This clinical trial study for heart attack is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06139328 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06139328 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.